Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer
Autor: | Adrian Arendowski, Krzysztof Ossoliński, Valérie Copié, Tomasz Ruman, Joanna Nizioł, Brian P. Tripet |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Magnetic Resonance Spectroscopy Metabolite Kidney Mass spectrometry Biochemistry Gastroenterology Analytical Chemistry 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Metabolomics Internal medicine Biomarkers Tumor medicine Humans Cancer Aged 030304 developmental biology Aged 80 and over 0303 health sciences Surface-assisted laser desorption/ionization business.industry Proton nuclear magnetic resonance Middle Aged medicine.disease Kidney Neoplasms medicine.anatomical_structure chemistry Case-Control Studies 030220 oncology & carcinogenesis Biomarker (medicine) Female business Kidney cancer Biomarkers Research Paper |
Zdroj: | Analytical and Bioanalytical Chemistry |
ISSN: | 1618-2650 1618-2642 |
DOI: | 10.1007/s00216-020-02807-1 |
Popis: | Kidney cancer is one of the most frequently diagnosed and the most lethal urinary cancer. Despite all the efforts made, no serum-specific biomarker is currently used in the clinical management of patients with this tumor. In this study, comprehensive high-resolution proton nuclear magnetic resonance spectroscopy (1H NMR) and silver-109 nanoparticle-enhanced steel target laser desorption/ionization mass spectrometry (109AgNPET LDI MS) approaches were conducted, in conjunction with multivariate data analysis, to discriminate the global serum metabolic profiles of kidney cancer (n = 50) and healthy volunteers (n = 49). Eight potential biomarkers have been identified using 1H NMR metabolomics and nine mass spectral features which differed significantly (p 2 > 0.7), area under the receiver operative characteristic curve (ROC) AUC > 0.96. Compared with healthy human serum, kidney cancer serum had higher levels of glucose and lower levels of choline, glycerol, glycine, lactate, leucine, myo-inositol, and 1-methylhistidine. Analysis of differences between these metabolite levels in patients with different types and grades of kidney cancer was undertaken. Our results, derived from the combination of LDI MS and 1H NMR methods, suggest that serum biomarkers identified herein appeared to have great potential for use in clinical prognosis and/or diagnosis of kidney cancer. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |